The Chinese NDRC sanctions three pharmaceutical companies for price fixing and joint boycotts (Huazhong Yaoye / Shandong Xinyi / Changzhou Siyao)

On 22 July 2016, the NDRC sanctioned 3 pharmaceutical companies for engaging in price fixing and joint boycotts in relation to estazolam tablets and active pharmaceutical ingredients (API), in breach of Articles 13(1)(1) and 13(1)(5) of the Anti-Monopoly Law (AML). The 3 companies (Huazhong Yaoye,

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

  • China Competition Bulletin (Beijing)
  • University of Melbourne
  • University of Melbourne
  • Hogan Lovells (Beijing)

Quotation

Xiaoye Wang, Allan Fels, Wendy Ng, Adrian Emch, The Chinese NDRC sanctions three pharmaceutical companies for price fixing and joint boycotts (Huazhong Yaoye / Shandong Xinyi / Changzhou Siyao), 22 July 2016, e-Competitions Bulletin Competition in the Pharmaceutical sector, Art. N° 88619

Visites 53

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues